About Ilico Genetics
Ilico Genetics is a company based in Bethlehem (United States) founded in 2020 by Fernando Alarcon Hardy, Alejandro Corvalan, and Maria Maturana.. Ilico Genetics has raised $457.74 thousand across 1 funding round. Ilico Genetics offers products and services including Stomach Cancer Screening Test. Ilico Genetics operates in a competitive market with competitors including Intima Bioscience, Draconis Pharma, Shgsmed.com, Checkmate Therapeutics and TLR Therapeutics, among others.
- Headquarter Bethlehem, United States
- Founders Fernando Alarcon Hardy, Alejandro Corvalan, Maria Maturana
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$457.74 K (USD)
in 1 rounds
-
Latest Funding Round
$457.74 K (USD), Seed
Oct 27, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ilico Genetics
Ilico Genetics offers a comprehensive portfolio of products and services, including Stomach Cancer Screening Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood test to detect early-stage gastric cancer before symptoms.
Unlock access to complete
Unlock access to complete
Funding Insights of Ilico Genetics
Ilico Genetics has successfully raised a total of $457.74K through 1 strategic funding round. The most recent funding activity was a Seed round of $457.74 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $457,735
-
First Round
First Round
(27 Oct 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Seed - Ilico Genetics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Ilico Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ilico Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ilico Genetics Comparisons
Competitors of Ilico Genetics
Ilico Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intima Bioscience, Draconis Pharma, Shgsmed.com, Checkmate Therapeutics and TLR Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for cancer, pain, and immune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for esophageal cancer treatment are developed using photodynamic therapy.
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutic technologies for cancer and neurological disorders.
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ilico Genetics
When was Ilico Genetics founded?
Ilico Genetics was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Where is Ilico Genetics located?
Ilico Genetics is headquartered in Bethlehem, United States.
Who is the current CEO of Ilico Genetics?
Fernando Alarcon Hardy is the current CEO of Ilico Genetics. They have also founded this company.
Is Ilico Genetics a funded company?
Ilico Genetics is a funded company, having raised a total of $457.74K across 1 funding round to date. The company's 1st funding round was a Seed of $457.74K, raised on Oct 27, 2023.
What does Ilico Genetics do?
Ilico Genetics was founded in 2020 in Bethlehem, United States, within the biotechnology sector. Diagnostic tests for gastric cancer are developed, focusing on molecular analysis of methylated DNA obtained from blood samples. Tumors or lesions in the stomach are detected through this non-invasive method. Operations center on advancing early detection technologies for oncology applications in the diagnostic industry.
Who are the top competitors of Ilico Genetics?
Ilico Genetics's top competitors include Draconis Pharma, Intima Bioscience and Shgsmed.com.
What products or services does Ilico Genetics offer?
Ilico Genetics offers Stomach Cancer Screening Test.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.